A similar decrease in proliferation occurred in melanoma, Kaposi’s sarcoma cell lines and more recently in prostate cancer cells in vitro and in vivo, following HSPG2 downregulation using antisense27,30,31. This evidence concerns the gene HSPG2 and Kaposi's sarcoma.